英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
genomes查看　genomes　在百度字典中的解释百度英翻中〔查看〕
genomes查看　genomes　在Google字典中的解释Google英翻中〔查看〕
genomes查看　genomes　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Techmeme: Boston-based Maven, which builds autonomous AI agents for . . .
    Chris Metinko Axios: Boston-based Maven, which builds autonomous AI agents for enterprises' customer support, raised a $50M Series B led by Dell, taking its total funding to $78M Open Links In New Tab Mobile Archives Advertise June 18, 2025, 11:00 AM Enter Techmeme snapshot date and time:
  • Maven AGI Raises $50 Million in Series B | The SaaS News
    Maven AGI, a Boston-based enterprise AI company focused on unifying the customer journey, has raised $50 million in Series B funding, bringing its total funding to $78 million Investors The round was led by Dell Technologies Capital, with participation from Cisco Investments, SE Ventures (backed by Schneider Electric), and existing backers Lux
  • Ratio Therapeutics Announces $50M Series B Financing to . . . - BioSpace
    Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90 Million Since 2021 Launch BOSTON, Jan 17, 2024 PRNewswire -- Ratio Therapeutics Inc (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for the treatment and monitoring of cancers, today announces the close of its $50M Series B
  • Maven AGI raises $50m in Series B funding, Kate Wang
    Boston based developer of AI agents for customer experience raised $50m in Series B funding led by Dell Technologies Capital, Cisco Investments, and SE Ventures "Maven AGI is tackling one of the fastest-growing markets globally, and they've assembled a team with unmatched expertise in customer experience and AI "
  • Boston-based Maven, which builds autonomous AI agents for enterprises . . .
    Chris Metinko Axios: Boston-based Maven, which builds autonomous AI agents for enterprises' customer support, raised a $50M Series B led by Dell, taking its total funding to $78M — Maven AGI, which builds enterprise AI agents for customer support, raised a $50 million Series B led by Dell Technologies Capital …
  • Exclusive: Maven AGI raises $50M Series B - Axios
    Founded in 2023, the Boston-based company has now raised a total of $78 million By the numbers: In less than 12 months, Maven has scaled from zero to $7 million in annual recurring revenue, per the company It has signed up 30 enterprise customers in its first year, including Tripadvisor, Clio and Paris Hilton's Parivie beauty line
  • Ratio Therapeutics Secures $50M Series B to Develop Cancer Treatments
    Ratio Therapeutics Secures $50M Series B to Develop Cancer Treatments Boston-based pharmaceutical company Ratio Therapeutics has announced the completion of a $50 million Series B financing round to advance its targeted radiotherapies for cancer treatment The funding brings Ratio’s total raised capital to more than $90 million since its
  • Ratio Therapeutics Raises $50M in Series B Financing
    The Boston-based firm plans to put the funding toward advancing its fibroblast activation protein-alpha (FAP)-targeted radiopharmaceutical therapies Ratio Therapeutics Raises $50M in Series B Financing Jan 17, 2024 | staff reporter Save for later NEW YORK – Ratio Therapeutics on Wednesday announced that it has raised $50 million in a
  • Maven AGI 2025 Company Profile: Valuation, Funding Investors - PitchBook
    Early Stage VC (Series A) 25-Mar-2024: $20M: Completed: Generating Revenue: 1 Seed Round: 11-Aug-2023: Completed: Generating Revenue: To view Maven AGI’s complete valuation and funding history, request access » Maven AGI Cap Table Stock # of Shares Authorized Par Value Dividend Rate (%) Original Issue Price Liquidation Liquidation
  • January 17th, 2024: Ratio Therapeutics Announces $50M Series B . . .
    Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90Million Since 2021 Launch BOSTON, January 17, 2024 – Ratio Therapeutics Inc (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for the treatment and monitoring of cancers, today announces the close of its $50M Series B financing





中文字典-英文字典  2005-2009